Tag Archives: Liposome Drug Delivery Market

The liposome drug delivery market is expected to witness a CAGR 8.7% during the forecast period of 2023 to 2031. The advancements in drug delivery technology, particularly in the context of oncology and infectious diseases, drive the liposome drug delivery market. However, manufacturing difficulties and the lack of standardization continue to be significant obstacles. With evolving liposome structures and product ...